{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T13:50:37Z","timestamp":1779889837537,"version":"3.53.1"},"reference-count":11,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,3,12]],"date-time":"2014-03-12T00:00:00Z","timestamp":1394582400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["journal-of-hepatology.eu","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.jhep.2014.01.032","type":"journal-article","created":{"date-parts":[[2014,3,19]],"date-time":"2014-03-19T12:00:58Z","timestamp":1395230458000},"page":"169-170","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Anti-TNF-induced autoimmune hepatitis"],"prefix":"10.1016","volume":"61","author":[{"given":"Meredith A.","family":"Borman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Urbanski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark G.","family":"Swain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2014.01.032_b0005","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jhep.2012.11.010","article-title":"Infliximab as a rescue treatment in difficult-to-treat autoimmune hepatitis","volume":"58","author":"Weiler-Normann","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2014.01.032_b0010","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/BOR.0b013e32835b1366","article-title":"Biologics-induced autoimmune diseases","volume":"25","author":"Perez-Alvarez","year":"2013","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.jhep.2014.01.032_b0015","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.autrev.2009.10.003","article-title":"Autoimmune diseases induced by biological agents: a double-edged sword?","volume":"9","author":"Ramos-Casals","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jhep.2014.01.032_b0020","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1007\/s00228-011-1191-4","article-title":"Autoimmune hepatitis induced by adalimumab with successful switch to abatacept","volume":"68","author":"Grasland","year":"2012","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jhep.2014.01.032_b0025","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1007\/s10067-005-0169-y","article-title":"Serious liver disease induced by infliximab","volume":"26","author":"Tobon","year":"2007","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jhep.2014.01.032_b0030","doi-asserted-by":"crossref","first-page":"3386","DOI":"10.1007\/s10620-011-1748-1","article-title":"Infliximab-induced autoimmune hepatitis with successful switch to adalimumab in a patient with Crohn\u2019s disease: the index case","volume":"56","author":"Goldfeld","year":"2011","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jhep.2014.01.032_b0035","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s10067-006-0253-y","article-title":"Successful treatment with etanercept in a patient with hepatotoxicity closely related to infliximab","volume":"26","author":"Aparicio","year":"2007","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jhep.2014.01.032_b0040","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.jbspin.2007.12.009","article-title":"Infliximab-induced hepatitis: absence of cross-toxicity with etanercept","volume":"75","author":"Thiefin","year":"2008","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jhep.2014.01.032_b0045","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/BOR.0b013e32832f13db","article-title":"Drug-induced autoimmunity","volume":"21","author":"Dedeoglu","year":"2009","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.jhep.2014.01.032_b0050","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S1359-6101(02)00019-9","article-title":"Role of TNF\/TNFR in autoimmunity: specific TNF receptor blockade may be advantageous to anti-TNF treatment","volume":"13","author":"Kollias","year":"2002","journal-title":"Cytokine Growth Fact Rev"},{"key":"10.1016\/j.jhep.2014.01.032_b0055","doi-asserted-by":"crossref","first-page":"3611","DOI":"10.1016\/j.febslet.2011.04.025","article-title":"Contrasting effects of TNF and anti-TNF on activation of effector T cells and regulatory T cells in autoimmunity","volume":"585","author":"Chen","year":"2011","journal-title":"FEBS Lett"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827814001469?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827814001469?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,6]],"date-time":"2018-10-06T00:23:47Z","timestamp":1538785427000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827814001469"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":11,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S0168827814001469"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2014.01.032","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-TNF-induced autoimmune hepatitis","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2014.01.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2012.11.010","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2014 European Association for the Study of the Liver. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}